In vivo evaluation of a novel albumin-binding prodrug of doxorubicin in an orthotopic mouse model of prostate cancer (LNCaP). [electronic resource]
Producer: 20110606Description: 14-21 p. digitalISSN:- 1476-5608
- Animals
- Antibiotics, Antineoplastic -- metabolism
- Cell Line, Tumor
- Disease Models, Animal
- Doxorubicin -- metabolism
- Humans
- Male
- Mice
- Mice, SCID
- Neoplasm Transplantation
- Prodrugs -- metabolism
- Prostate-Specific Antigen -- blood
- Prostatic Neoplasms -- drug therapy
- Serum Albumin -- metabolism
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.